Cabazitaxel injection - Accord HealthcareAlternative Names: Cabazitaxel - Accord Helathcare
Latest Information Update: 14 Jul 2015
At a glance
- Originator Accord Healthcare
- Class Antineoplastics; Taxanes
- Mechanism of Action Tubulin polymerisation promoters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preregistration Prostate cancer
Most Recent Events
- 15 Mar 2016 Biomarkers information updated